Wecome Pharmaceutical Co Ltd (300878) - Total Liabilities

Latest as of September 2025: CN¥458.37 Million CNY ≈ $67.07 Million USD

Based on the latest financial reports, Wecome Pharmaceutical Co Ltd (300878) has total liabilities worth CN¥458.37 Million CNY (≈ $67.07 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 300878 net assets growth trend to track the company's year-over-year net asset growth rate.

Wecome Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Wecome Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300878 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Wecome Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wecome Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Ningbo Baosi Energy Equipment Co Ltd
SHE:300441
China CN¥1.23 Billion
APAQ Technology Co Ltd
TW:6449
Taiwan NT$4.06 Billion
Ardmore Shipping Corporation
F:A61
Germany €154.39 Million
Sri Trang Agro-Industry Public Company Limited
BK:STA-R
Thailand ฿40.18 Billion
Leong Hup International Berhad
KLSE:6633
Malaysia RM3.06 Billion
Fastighetsbolaget Emilshus AB
ST:EMIL-B
Sweden Skr7.53 Billion
Zhejiang Noblelift Equip
SHG:603611
China CN¥6.33 Billion
Jiahe Foods Industry Co. Ltd.
SHG:605300
China CN¥668.93 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Wecome Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Wecome Pharmaceutical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.45 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.31 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wecome Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wecome Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual total liabilities of Wecome Pharmaceutical Co Ltd from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥478.50 Million
≈ $70.02 Million
-25.14%
2023-12-31 CN¥639.23 Million
≈ $93.54 Million
+27.27%
2022-12-31 CN¥502.25 Million
≈ $73.50 Million
+76.67%
2021-12-31 CN¥284.28 Million
≈ $41.60 Million
+16.32%
2020-12-31 CN¥244.39 Million
≈ $35.76 Million
-31.35%
2019-12-31 CN¥356.02 Million
≈ $52.10 Million
+43.97%
2018-12-31 CN¥247.29 Million
≈ $36.19 Million
+42.38%
2017-12-31 CN¥173.68 Million
≈ $25.42 Million
+66.61%
2016-12-31 CN¥104.25 Million
≈ $15.25 Million
+13.51%
2015-12-31 CN¥91.84 Million
≈ $13.44 Million
-3.14%
2014-12-31 CN¥94.82 Million
≈ $13.88 Million
+30.28%
2013-12-31 CN¥72.78 Million
≈ $10.65 Million
--

About Wecome Pharmaceutical Co Ltd

SHE:300878 China Biotechnology
Market Cap
$651.09 Million
CN¥4.45 Billion CNY
Market Cap Rank
#10844 Global
#2935 in China
Share Price
CN¥30.73
Change (1 day)
+5.35%
52-Week Range
CN¥20.49 - CN¥39.45
All Time High
CN¥52.21
About

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly k… Read more